Document is current
Any future updates will be listed below
-
Authors
Tang, Chad https://orcid.org/0000-0002-5915-1327
Hartley, Genevieve P
Couillault, Coline
Yuan, Ying
Lin, Heather
Nicholas, Courtney
Srinivasamani, Anupallavi
Dai, James
Dumbrava, Ecaterina E Ileana
Fu, Siqing
Karp, Daniel D
Naing, Aung https://orcid.org/0000-0002-4803-8513
Piha-Paul, Sarina A https://orcid.org/0000-0001-9455-1660
Rodon Ahnert, Jordi
Pant, Shubham
Subbiah, Vivek
Yap, Timonthy A
Tsimberidou, Apostolia M https://orcid.org/0000-0003-2713-233X
Guerrero, Paola
Dhebat, Sarah
Proia, Theresa
Curran, Michael A
Hong, David S
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02983578 at ClinicalTrials.govnct01563302 at ClinicalTrials.govDocuments that mention this clinical trial
Longitudinal plasma proteomic profiling of patients with non-small cell lung cancer undergoing immune checkpoint blockade
https://doi.org/10.1136/jitc-2022-004582
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
https://doi.org/10.1136/bmjonc-2023-000133
nct01839604 at ClinicalTrials.govDocuments that mention this clinical trial
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
https://doi.org/10.1136/bmjonc-2023-000133
Documents that mention this clinical trial
Preclinical study and parallel phase II trial evaluating antisense STAT3 oligonucleotide and checkpoint blockade for advanced pancreatic, non-small cell lung cancer and mismatch repair-deficient colorectal cancer
https://doi.org/10.1136/bmjonc-2023-000133
Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches
https://doi.org/10.1136/gutjnl-2014-307990
-
Funding
Funding for this research was provided by:
Clinical Center (P30 CA016672)
AstraZeneca (N/A)
- License Information
